SEK155.10
0.45% today
Stockholm, Jun 12, 11:39 am CET
ISIN
SE0014428512
Symbol
SUS
Sector

Surgical Science Sweden AB Stock price

SEK155.80
+5.30 3.52% 1M
+4.80 3.18% 6M
-0.10 0.06% YTD
+16.30 11.68% 1Y
+97.75 168.39% 5Y
+97.05 165.19% 10Y
+97.05 165.19% 20Y
Stockholm, Closing price Wed, Jun 11 2025
-3.40 2.14%
ISIN
SE0014428512
Symbol
SUS
Sector

Key metrics

Market capitalization SEK8.12b
Enterprise Value SEK7.51b
P/E (TTM) P/E ratio 56.25
EV/FCF (TTM) EV/FCF 134.24
EV/Sales (TTM) EV/Sales 7.94
P/S ratio (TTM) P/S ratio 8.58
P/B ratio (TTM) P/B ratio 1.78
Revenue growth (TTM) Revenue growth 12.41%
Revenue (TTM) Revenue SEK946.54m
EBIT (operating result TTM) EBIT SEK142.28m
Free Cash Flow (TTM) Free Cash Flow SEK55.96m
Cash position SEK612.89m
EPS (TTM) EPS SEK2.77
P/E forward 40.71
P/S forward 7.17
EV/Sales forward 6.63
Show more

Is Surgical Science Sweden AB a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,842 stocks worldwide.

Surgical Science Sweden AB Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a Surgical Science Sweden AB forecast:

3x Buy
75%
1x Hold
25%

Analyst Opinions

4 Analysts have issued a Surgical Science Sweden AB forecast:

Buy
75%
Hold
25%

Financial data from Surgical Science Sweden AB

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
947 947
12% 12%
100%
- Direct Costs 299 299
13% 13%
32%
647 647
12% 12%
68%
- Selling and Administrative Expenses 261 261
12% 12%
28%
- Research and Development Expense 189 189
5% 5%
20%
191 191
-
20%
- Depreciation and Amortization 49 49
-
5%
EBIT (Operating Income) EBIT 142 142
12% 12%
15%
Net Profit 141 141
32% 32%
15%

In millions SEK.

Don't miss a Thing! We will send you all news about Surgical Science Sweden AB directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Surgical Science Sweden AB engages in the development of simulators for laparoscopic medical training. Its products include LapSim, offers a procedural simulation for cholecystectomy, appendectomy, advanced suturing and anastomosis, gynecology, hysterectomy, bariatrics, and nephrectomy; EndoSim, for endoscopy simulation; and TeamSim, for realistic training of collaboration within a surgery team. The company was founded by Anders Hyltander, David Löfstrand, and Anders Larsson on July 24, 1997 and is headquartered in Gothenburg, Sweden.

Head office Sweden
CEO Mr. Englund
Employees 274
Founded 1997
Website surgicalscience.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today